(R)-N-(1-(3-acrylamidophenylsulfonyl)pyrrolidin-3-yl)-4-(2,6-dichlorobenzamido)-1H-pyrazole-3-carboxamide 2,2,2-trifluoroacetate

ID: ALA4536778

PubChem CID: 155548645

Max Phase: Preclinical

Molecular Formula: C27H25Cl2F3N6O7S

Molecular Weight: 591.48

Molecule Type: Unknown

Names and Identifiers

Canonical SMILES:  C/C=C/C(=O)Nc1cccc(S(=O)(=O)N2CC[C@@H](NC(=O)c3n[nH]cc3NC(=O)c3c(Cl)cccc3Cl)C2)c1.O=C(O)C(F)(F)F

Standard InChI:  InChI=1S/C25H24Cl2N6O5S.C2HF3O2/c1-2-5-21(34)29-15-6-3-7-17(12-15)39(37,38)33-11-10-16(14-33)30-25(36)23-20(13-28-32-23)31-24(35)22-18(26)8-4-9-19(22)27;3-2(4,5)1(6)7/h2-9,12-13,16H,10-11,14H2,1H3,(H,28,32)(H,29,34)(H,30,36)(H,31,35);(H,6,7)/b5-2+;/t16-;/m1./s1

Standard InChI Key:  SJYVNEQKHYLYSN-WOQRJVAFSA-N

Molfile:  

     RDKit          2D

 46 48  0  0  0  0  0  0  0  0999 V2000
    8.8701  -29.5591    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.5846  -29.1466    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.1556  -29.1466    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    8.8701  -30.3841    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    8.1534  -29.9674    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   10.2990  -29.5591    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.5846  -28.3215    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.2459  -25.4127    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.4625  -26.2127    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   10.0471  -25.6250    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.8250  -27.9377    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6500  -27.9377    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.4125  -27.2232    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.4125  -28.6522    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5884  -28.6493    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1760  -29.3630    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5885  -30.0785    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4178  -30.0759    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8265  -29.3616    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1772  -27.9341    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    4.6515  -29.3581    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    6.3001  -27.9377    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0625  -27.2254    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8876  -27.2232    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1405  -26.4379    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.4716  -25.9546    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.8055  -26.4414    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1251  -27.9377    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.8876  -28.6522    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.6066  -27.2679    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4316  -27.2614    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.6826  -26.4755    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.0128  -25.9938    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.3479  -26.4821    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.0819  -26.7657    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.9095  -27.5705    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.5244  -28.1192    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.3087  -27.8606    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.4746  -27.0481    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.8582  -26.5028    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.2570  -26.7865    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   12.4218  -25.9781    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.2042  -25.7166    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.8040  -25.4313    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   13.3688  -24.9081    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.1512  -24.6465    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  1  0
  1  4  1  0
  1  5  1  0
  2  6  1  0
  2  7  2  0
  9  8  2  0
 10  9  2  0
 11 12  1  0
 11 13  2  0
 11 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 14  1  0
 15 20  1  0
 19 21  1  0
 12 23  1  0
 24 22  1  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  1  0
 27 23  2  0
 22 28  1  0
 22 29  2  0
 30 28  1  6
 30 31  1  0
 31 32  1  0
 32 33  1  0
 33 34  1  0
 34 30  1  0
 32  9  1  0
  9 35  1  0
 35 36  2  0
 36 37  1  0
 37 38  2  0
 38 39  1  0
 39 40  2  0
 40 35  1  0
 39 41  1  0
 41 42  1  0
 42 43  1  0
 42 44  2  0
 43 45  2  0
 45 46  1  0
M  END

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Unknown

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 591.48

Molecular Weight (Monoisotopic): 590.0906

AlogP: 3.68

#Rotatable Bonds: 8

Polar Surface Area: 153.36

Molecular Species: NEUTRAL

HBA: 6

HBD: 4

#RO5 Violations: 1

HBA (Lipinski): 11

HBD (Lipinski): 4

#RO5 Violations (Lipinski): 2

CX Acidic pKa: 10.75

CX Basic pKa: 0.02

CX LogP: 3.87

CX LogD: 3.87

Aromatic Rings: 3

Heavy Atoms: 39

QED Weighted: 0.29

Np Likeness Score: -1.91

References

1. Ferguson FM, Doctor ZM, Ficarro SB, Marto JA, Kim ND, Sim T, Gray NS..  (2019)  Synthesis and structure activity relationships of a series of 4-amino-1H-pyrazoles as covalent inhibitors of CDK14.,  29  (15): [PMID:31175010] [10.1016/j.bmcl.2019.05.024]

Source

Source(1):

• Scientific Literature